JZJuan Zhang

Juan Zhang

*This is an algorithmically generated author record based on publicly available information.

Juan Zhang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Chaowen Yu

    Center for Clinical Molecular Medicine & Newborn Screening, Children’s Hospital of Chongqing Medical University; National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China

    1 shared publication
  • Dong-Juan Wang

    Center for Clinical Molecular Medicine, Chongqing, 400014, People's Republic of China

    1 shared publication
  • Hao Liu

    Newborn Screening Center, Department of Pediatrics, Chongqing Health Center for Women and Children/Women and Children’s Hospital of Chongqing Medical University, Chongqing, China

    1 shared publication
  • Jing Yang

    Center for Clinical Molecular Medicine, Chongqing, 400014, People's Republic of China

    1 shared publication
  • Jingkun Miao

    Department of Pediatrics, Chongqing Health Center for Women and Children, Chongqing, China

    1 shared publication
  • Ke-Xing Wan

    Center for Clinical Molecular Medicine, Chongqing, 400014, People's Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Severe clinical manifestation of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency associated with two novel mutations: a case report

    by Hao Liu, Jing-Kun Miao, Chao-Wen Yu, Ke-Xing Wan, Juan Zhang, Zhao-Jian Yuan, Jing Yang, Dong-Juan Wang, Yan Zeng, Lin Zou

    Background: Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase (mHS) deficiency is an autosomal recessive inborn error of metabolism, which will give rise to failure of ketogenesis in liver during illness or fasting. It is a very rare disease with only a few patients reported worldwide, most of which had a good prognosis after proper therapies. Case presentation: We report a 9-month-old boy with mHS deficiency presenting with unusually severe and persistent acidosis after diarrhea and reduced oral food intake. The metabolic acidosis persisted even after supplementation with sugar and alkaline solution. Blood purification and assisted respiration alleviated symptoms, but a second onset induced by respiratory infection several days later led to multiple organ failure and death. Urine organic acid analysis during the acute episode revealed a complex pattern of ketogenic dicarboxylic and 3-hydroxydicarboxylic aciduria with prominent elevation of glutaric acid and adipic acid, which seem to be specific to mHS deficiency. Plasma acylcarnitine analysis revealed elevated 3-hydroxybutyrylcarnitine and acetylcarnitine. This is the first report of elevated 3-hydroxybutyrylcarnitine in mHS deficiency. Whole exome sequencing revealed a novel compound heterozygous mutation in HMGCS2 (c.100C > T and c.1465delA). Conclusion: This severe case suggests the need for patients with mHS deficiency to avoid recurrent illness because it can induce severe metabolic crisis, possibly leading to death. Such patients may also require special treatment, such as blood purification. Urine organic acid profile during the acute episode may give a hint to the disease.